The Practice Committee of the Society for Assisted Reproductive Technology and the Practice Committee of the American Society for Reproductive Medicine
American Society for Reproductive Medicine, Birmingham, Alabama
Oocyte cryopreservation is an experimental procedure that should not be offered or marketed as a means to defer reproductive aging, primarily because data relating to clinical outcomes are limited.
(1) Nonetheless, many women understandably have interest in this emerging technology and view oocyte cryopreservation as an elective fertility preservation strategy that may help them to realize their longer-term reproductive goals. Oocyte cryopreservation is not an established medical treatment. Women who may be considering the procedure must be informed fully about the process involved and the clinical outcomes that reasonably can be expected so that they can make a truly informed decision and give valid consent. Counseling by a qualified mental health professional also should be provided. Read full article (PDF)